Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TISAGENLECLEUCEL vs TOBRAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TISAGENLECLEUCEL vs TOBRAMYCIN: Safety Overview

Metric TISAGENLECLEUCEL TOBRAMYCIN
Total FAERS Reports 4,229 11,597
Deaths Reported 1,232 1,306
Death Rate 29.1% 11.3%
Hospitalizations 1,256 5,106
Average Patient Age 39.1 yrs 38.0 yrs
% Female Patients 38.4% 54.0%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation Lifestar Pharma LLC
Route INTRAVENOUS RESPIRATORY (INHALATION)
Marketing Status N/A Discontinued